Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216156985> ?p ?o ?g. }
- W3216156985 abstract "In the Thai RV144 HIV-1 vaccine trial, a three-variant haplotype within the Fc gamma receptor 2C gene (FCGR2C) reduced the risk of HIV-1 acquisition. A follow-on trial, HVTN702, of a similar vaccine candidate found no efficacy in South Africa, where the predominant population is polymorphic for only a single variant in the haplotype, c.134-96C>T (rs114945036). To investigate a role for this variant in HIV-1 acquisition in South Africans, we used the model of maternal-infant HIV-1 transmission. A nested case-control study was conducted of infants born to mothers living with HIV-1, comparing children with perinatally-acquired HIV-1 (cases, n = 176) to HIV-1-exposed uninfected children (controls, n = 349). All had received nevirapine for prevention of mother-to-child transmission. The FCGR2C copy number and expression variants (c.-386G>C, c.-120A>T c.169T>C, and c.798+1A>G) were determined using a multiplex ligation-dependent probe amplification assay and the c.134-96C>T genotype with Sanger sequencing. The copy number, genotype and allele carriage were compared between groups using univariate and multivariate logistic regression. The FCGR2C c.134-96C>T genotype distribution and copy number differed significantly between HIV-1 cases and exposed-uninfected controls (P = 0.002, PBonf = 0.032 and P = 0.010, PBonf = > 0.05, respectively). The FCGR2C c.134-96T allele was overrepresented in the cases compared to the controls (58% vs 42%; P = 0.001, PBonf = 0.016). Adjusting for birthweight and FCGR2C copy number, perinatal HIV-1 acquisition was associated with the c.134-96C>T (AOR = 1.89; 95% CI 1.25-2.87; P = 0.003, PBonf = 0.048) and c.169C>T (AOR = 2.39; 95% CI 1.45-3.95; P = 0.001, PBonf = 0.016) minor alleles but not the promoter variant at position c.-386G>C. The c.134-96C>T variant was in strong linkage disequilibrium with the c.169C>T variant, but remained significantly associated with perinatal acquisition when adjusted for c.169C>T in multivariate analysis. In contrast to the protective effect observed in the Thai RV144 trial, we found the FCGR2C variant c.134-96T-allele associated with increased odds of perinatal HIV-1 acquisition in South African children. These findings, taken together with a similar deleterious association found with HIV-1 disease progression in South African adults, highlight the importance of elucidating the functional relevance of this variant in different populations and vaccination/disease contexts." @default.
- W3216156985 created "2021-12-06" @default.
- W3216156985 creator A5011671349 @default.
- W3216156985 creator A5019349011 @default.
- W3216156985 creator A5022511811 @default.
- W3216156985 creator A5036152130 @default.
- W3216156985 creator A5043806838 @default.
- W3216156985 creator A5056640792 @default.
- W3216156985 creator A5065078265 @default.
- W3216156985 creator A5066484554 @default.
- W3216156985 date "2021-11-30" @default.
- W3216156985 modified "2023-10-15" @default.
- W3216156985 title "An HIV Vaccine Protective Allele in FCGR2C Associates With Increased Odds of Perinatal HIV Acquisition" @default.
- W3216156985 cites W1543394342 @default.
- W3216156985 cites W1605924676 @default.
- W3216156985 cites W1622362352 @default.
- W3216156985 cites W1818776176 @default.
- W3216156985 cites W1922278110 @default.
- W3216156985 cites W1939864032 @default.
- W3216156985 cites W1975039969 @default.
- W3216156985 cites W1980655909 @default.
- W3216156985 cites W1995188936 @default.
- W3216156985 cites W2014606320 @default.
- W3216156985 cites W2019432978 @default.
- W3216156985 cites W2064640882 @default.
- W3216156985 cites W2066409900 @default.
- W3216156985 cites W2070919702 @default.
- W3216156985 cites W2075901113 @default.
- W3216156985 cites W2082836772 @default.
- W3216156985 cites W2083298987 @default.
- W3216156985 cites W2091583999 @default.
- W3216156985 cites W2094340292 @default.
- W3216156985 cites W2105692976 @default.
- W3216156985 cites W2146343022 @default.
- W3216156985 cites W2154805031 @default.
- W3216156985 cites W2157593793 @default.
- W3216156985 cites W2162530578 @default.
- W3216156985 cites W2206603153 @default.
- W3216156985 cites W2307946095 @default.
- W3216156985 cites W2309021002 @default.
- W3216156985 cites W2319193381 @default.
- W3216156985 cites W2409473104 @default.
- W3216156985 cites W2806024756 @default.
- W3216156985 cites W2904279561 @default.
- W3216156985 cites W2936929400 @default.
- W3216156985 cites W2944662565 @default.
- W3216156985 cites W2969800851 @default.
- W3216156985 cites W2973305373 @default.
- W3216156985 cites W3007190233 @default.
- W3216156985 cites W3137307641 @default.
- W3216156985 cites W3138945586 @default.
- W3216156985 doi "https://doi.org/10.3389/fimmu.2021.760571" @default.
- W3216156985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34917081" @default.
- W3216156985 hasPublicationYear "2021" @default.
- W3216156985 type Work @default.
- W3216156985 sameAs 3216156985 @default.
- W3216156985 citedByCount "2" @default.
- W3216156985 countsByYear W32161569852021 @default.
- W3216156985 countsByYear W32161569852022 @default.
- W3216156985 crossrefType "journal-article" @default.
- W3216156985 hasAuthorship W3216156985A5011671349 @default.
- W3216156985 hasAuthorship W3216156985A5019349011 @default.
- W3216156985 hasAuthorship W3216156985A5022511811 @default.
- W3216156985 hasAuthorship W3216156985A5036152130 @default.
- W3216156985 hasAuthorship W3216156985A5043806838 @default.
- W3216156985 hasAuthorship W3216156985A5056640792 @default.
- W3216156985 hasAuthorship W3216156985A5065078265 @default.
- W3216156985 hasAuthorship W3216156985A5066484554 @default.
- W3216156985 hasBestOaLocation W32161569851 @default.
- W3216156985 hasConcept C104317684 @default.
- W3216156985 hasConcept C126322002 @default.
- W3216156985 hasConcept C135763542 @default.
- W3216156985 hasConcept C142462285 @default.
- W3216156985 hasConcept C156957248 @default.
- W3216156985 hasConcept C159047783 @default.
- W3216156985 hasConcept C180754005 @default.
- W3216156985 hasConcept C197754878 @default.
- W3216156985 hasConcept C203014093 @default.
- W3216156985 hasConcept C2779130552 @default.
- W3216156985 hasConcept C2908647359 @default.
- W3216156985 hasConcept C2993143319 @default.
- W3216156985 hasConcept C3013748606 @default.
- W3216156985 hasConcept C54355233 @default.
- W3216156985 hasConcept C71924100 @default.
- W3216156985 hasConcept C86803240 @default.
- W3216156985 hasConcept C99454951 @default.
- W3216156985 hasConceptScore W3216156985C104317684 @default.
- W3216156985 hasConceptScore W3216156985C126322002 @default.
- W3216156985 hasConceptScore W3216156985C135763542 @default.
- W3216156985 hasConceptScore W3216156985C142462285 @default.
- W3216156985 hasConceptScore W3216156985C156957248 @default.
- W3216156985 hasConceptScore W3216156985C159047783 @default.
- W3216156985 hasConceptScore W3216156985C180754005 @default.
- W3216156985 hasConceptScore W3216156985C197754878 @default.
- W3216156985 hasConceptScore W3216156985C203014093 @default.
- W3216156985 hasConceptScore W3216156985C2779130552 @default.
- W3216156985 hasConceptScore W3216156985C2908647359 @default.
- W3216156985 hasConceptScore W3216156985C2993143319 @default.
- W3216156985 hasConceptScore W3216156985C3013748606 @default.
- W3216156985 hasConceptScore W3216156985C54355233 @default.